Modern aspects of diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy in children
- 11 March 2024
- journal article
- abstracts
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (2) , 58-68
Abstract
OBJECTIVE Analysis of demographic, clinical, laboratory, electrophysiological and neuroimaging data and pathogenetic therapy of pediatric patients with chronic inflammatory demyelinating polyneuropathy (CIDP). MATERIAL AND METHODS Patients (n=30) were observed in a separate structural unit of the Russian Children’s Clinical Hospital of the Russian National Research Medical University named after. N.I. Pirogova Ministry of Health of the Russian Federation in the period from 2006 to 2023. The examination was carried out in accordance with the recommendations of the Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society on the Management of CIDP (2021). All patients received immunotherapy, including intravenous immunoglobulin (IVIG) (n=1), IVIG and glucocorticosteroids (GCS) (n=17, 56.7%), IVIG+GCS+plasmapheresis (n=12, 40.0%). Alternative therapy included cyclophosphamide (n=1), cyclophosphamide followed by mycophenolate mofetil (n=1), rituximab (n=2, 6.6%), azathioprine (n=3), mycophenolate mofetil (n=2, 6.6%). RESULTS In all patients, there was a significant difference between scores on the MRCss and INCAT functional scales before and after treatment. At the moment, 11/30 (36.6%) patients are in clinical remission and are not receiving pathogenetic therapy. The median duration of remission is 48 months (30—84). The longest remission (84 months) was observed in a patient with the onset of CIDP at the age of 1 year 7 months. CONCLUSION Early diagnosis of CIDP is important, since the disease is potentially curable; early administration of pathogenetic therapy provides a long-term favorable prognosis.Keywords
This publication has 85 references indexed in Scilit:
- Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathyCochrane Database of Systematic Reviews, 2017
- Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviewsCochrane Database of Systematic Reviews, 2017
- Long‐term Immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathyMuscle & Nerve, 2014
- Reconstruction magnetic resonance neurography in chronic inflammatory demyelinating polyneuropathyAnnals of Neurology, 2014
- Ultrasound differentiation of axonal and demyelinating neuropathiesMuscle & Nerve, 2014
- Clinical and electrophysiological parameters distinguishing acute‐onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathyMuscle & Nerve, 2009
- Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: Study of a UK populationMuscle & Nerve, 2009
- What is the best initial treatment for childhood chronic inflammatory demyelinating polyneuropathy: Corticosteroids or intravenous immunoglobulin?Muscle & Nerve, 2008
- Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathyAnnals of Neurology, 2001
- Chronic Inflammatory Demyelinating PolyradiculoneuropathyArchives of Neurology, 1989